Filing Details
- Accession Number:
- 0000899243-18-030319
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-06 20:13:51
- Reporting Period:
- 2018-10-31
- Accepted Time:
- 2018-12-06 20:13:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1696493 | June Lee | C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-10-31 | 344 | $42.16 | 770 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 5,000 | $11.95 | 5,770 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 2,800 | $60.08 | 2,970 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 1,200 | $61.07 | 1,770 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 800 | $62.26 | 970 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 200 | $63.76 | 770 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-12-03 | 5,000 | $0.00 | 5,000 | $11.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 140,000 | 2027-01-31 | No | 4 | M | Direct |
Footnotes
- Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Represents the weighted average sale price of the shares sold ranging from $59.58 to $60.54 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price of the shares sold ranging from $60.89 to $61.32 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price of the shares sold ranging from $62.11 to $62.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- 25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Billionaire Hedge Funds
